Additionally, fetuin-A, inter-α-trypsin, glutamic acid and cholesteryl ester 18:0 were collectively proposed as a novel panel of biomarkers to differentiate mild from critical COVID-19 outcomes (9). This evidence concerns the gene AHSG and COVID-19.